Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H. Mowry as President and Chief Executive Officer, effective immediately.
Sean D. Carney, Chairman of Tornier, commented, “Dave has demonstrated an intensity and concentration in executing on the key initiatives in his charge since joining Tornier in July 2011 as Chief Operating Officer. That expertise, combined with his extensive industry experience and outstanding leadership qualities, make Dave the right executive to continue to build Tornier’s strong brand and reputation in the extremities market.”
David H. Mowry commented, “Tornier’s industry expertise, broad product portfolio, and cadence of delivering innovation position the Company as a recognized global leader in the large and growing extremities markets. We believe the increased focus on execution of our US sales channel alignment, OrthoHelix integration, and delivering through our strong product pipeline will return Tornier to double-digit, constant currency revenue growth on a pro forma basis. I am grateful to the Board of Directors for the opportunity to lead Tornier, and I am excited to work with the talented and dedicated Tornier team.”
Mr. Mowry joined Tornier N.V. in July 2011 as Chief Operating Officer. He brings to Tornier 23 years of medical device industry experience in various engineering and management assignments. Prior to Tornier, Mr. Mowry served as Senior Vice President and President of the Neurovascular Division of Covidien plc, and in the same position with ev3 Inc., prior to its acquisition by Covidien. Before joining ev3, Mr. Mowry served as Vice President of Operations and Logistics at the Zimmer Spine division of Zimmer Holdings Inc. Mr. Mowry is a graduate of the United States Military Academy at West Point, New York with a degree in Engineering and Mathematics.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV